We don’t only report the news, we make the news. Our news highlights and archive here.
Interested in getting 24,000+ eyeballs to view your company’s content? Become a Santa Cruz Works Partner or, see 3rd party content Sponsors.
Unnatural Products, a Santa Cruz based biotech company developing orally-delivered macrocyclic peptides to address previously undruggable targets, announced the appointment of Simon Bailey, Ph.D., as Chief Operating Officer and President of R&D.
Read MoreUnnatural Products, maker of an AI-enhanced platform that creates entirely new drugs by engineering synthetic molecules to mimic nature’s macrocycles, recently announced that they received $32m in Series A funding.
Read MoreSanta Cruz is ripe with startups and “super-startups”. We list the top 10 to watch in 2022.
Read More
